In vivo assessment of Intrasynaptic dopamine in Parkinson patients following treatment with L-dopa or L-dopa/entacapone

被引：0

|

作者：

Seibyl, JP

Tabamo, R

Jennings, D

Tamagnan, G

Rabinowicz, A

Marek, K

机构：

来源：

MOVEMENT DISORDERS | 2005年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P149

引用

收藏

页码：S44 / S45

页数：2

相关论文

共 50 条

[1] The effects of different repeated doses of entacapone on the pharmacokinetics of L-Dopa and on the clinical response to L-Dopa in Parkinson's disease
Heikkinen, H
Nutt, JG
LeWitt, PA
Koller, WC
Gordin, A
CLINICAL NEUROPHARMACOLOGY, 2001, 24 (03) : 150 - 157
[2] L-DOPA, DOPAMINE, AND HYPOMANIA
MURPHY, DL
GOODWIN, FK
BRODIE, HKH
BUNNEY, WE
AMERICAN JOURNAL OF PSYCHIATRY, 1973, 130 (01): : 79 - 82
[3] Entacapone increases and extends striatal dopamine release following L-DOPA/benserazide treatment in the rat
Gerlach, M
van den Buuse, M
Blaha, C
Bremen, D
Riederer, P
MOVEMENT DISORDERS, 2004, 19 : S388 - S388
[4] PARKINSON THERAPY WITH L-DOPA
UMBACH, W
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1971, 96 (02) : 87 - &
[5] Entacapone and selegiline with L-dopa in patients with Parkinson's disease:: an interaction study
Lyytinen, J
Kaakkola, S
Gordin, A
Kultalahti, ER
Teräväinen, H
PARKINSONISM & RELATED DISORDERS, 2000, 6 (04) : 215 - 222
[6] RISKS OF PARKINSONISM TREATMENT WITH L-DOPA AND L-DOPA DECARBOXYLASE INHIBITOR
JORG, J
MEDIZINISCHE WELT, 1979, 30 (46): : 1740 - 1742
[7] L-dopa response in Parkinson's disease - A study with L-dopa infusion test
Saiki, H.
Matsumoto, S.
MOVEMENT DISORDERS, 2012, 27 : S50 - S50
[8] THE EFFECT OF CARBIDOPA ON PLASMA AND MUSCLE LEVELS OF L-DOPA, DOPAMINE, AND THEIR METABOLITES FOLLOWING L-DOPA ADMINISTRATION TO RATS
ROSE, S
JENNER, P
MARSDEN, CD
MOVEMENT DISORDERS, 1988, 3 (02) : 117 - 125
[9] INVIVO ASSESSMENT OF DECARBOXYLASE INHIBITION OR POTENTIATION - URINARY DOPAMINE AND L-DOPA OUTPUT AFTER L-DOPA ADMINISTRATION
JOHNSON, RD
RUTHVEN, CRJ
GOODWIN, BL
SANDLER, M
JOURNAL OF NEURAL TRANSMISSION, 1976, 38 (3-4) : 181 - 191
[10] TREATMENT OF PARKINSONS DISEASE WITH L-DOPA AND AN ASSOCIATION L-DOPA PLUS A DOPA DECARBOXYLASE INHIBITOR
FAZIO, C
BARBA, C
CASACCHIA, M
AGNOLI, A
RUGGIERI, S
VOLANTE, F
REITANO, M
ZEITSCHRIFT FUR NEUROLOGIE, 1972, 202 (04): : 347 - +

← 1 2 3 4 5 →